Hopes and Cures

Policy
·         Federal Grants for Entrepreneurs May Change
·         SBIR Funding for VC-Owned Firms
 
Awards
·         Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
·         Universal Display Corporation Awarded Phase I SBIR Grant from U.S. Air Force to Design Flexible OLED Display Prototype
·         Arkansas nanotechnology company gets $224,000 from EPA to develop “green” lighting

Filed under: In the News, SBIR, venture capital | Tagged: Air Force, Entrepreneur, EPA, Lentigen, SBIR | No Comments »

Venture-backed firms deserve SBIR grants
Washington Business Journal
Your article “House opens SBIR awards to VC-owned firms” (May 5-11) does an excellent job of discussing the technical aspects of the bill to reauthorize the Small Business Innovation Research program, but it does not say enough about the real-life opportunities it poses — for companies or for patients. [...]

Filed under: In the News, SBIR | Tagged: Business Journal, Gerald McGarrity, SBIR, vc-owned firms, Virxsys | No Comments »

Washington Business Journal
The House passed legislation that would make small businesses majority-owned by venture capital firms eligible for Small Business Innovation Research awards.
Through the SBIR program, 2.5 percent of the outside research budgets of 11 federal agencies — including the Department of Defense and the National Institutes of Health — is allocated for small [...]

Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, NIH, SBIR, small business innovation, Washington Business Journal | No Comments »

The National Dialogue on Entrepreneurship is following the SBIR Debate:

SBIR Bill Advances
A new proposal to reauthorize and modernize the Small Business Innovation Research (SBIR) program is making fast progress through Congress. Late last month, the House of Representatives overwhelmingly passed H.R. 5819, a bill to reauthorize the SBIR program—which directs federal research funds [...]

Filed under: In the News, SBIR, venture capital | Tagged: Congress, HR 5819, Phase I, SBIR, Technology | No Comments »

My name is Mark Leahey, and I am the Executive Director of the Medical Device Manufacturers Association (MDMA).  MDMA is a national trade association representing innovative, entrepreneurial medical technology companies across the country.  Our mission is to ensure that patients have timely access to the latest advancements in medical technology, most of which are developed [...]

Filed under: Congress, Non Profit, SBIR | Tagged: MDMA, medical technology, Phase I grants, SBIR | No Comments »

 
Alzheimer’s Drug Discovery Foundation
A new way to look at funding
The Alzheimer’s Drug Discovery Foundation (ADDF) raises money and awards grants to academic and biotechnology industry scientists who are conducting drug discovery research for Alzheimer’s Disease, related dementias and cognitive aging.
The way research is funded is evolving and by employing a venture capital model, [...]

Filed under: Finding Cures, SBIR, patient groups, venture capital | Tagged: Allon, Alzheimer's disease, Comentis, Estee Lauder, Fillit, SBIR | No Comments »

The Cystic Fibrosis Foundation today lauded the U.S. House of Representatives for passing legislation to reauthorize the Small Business Innovation Research (SBIR) program.
 

 
In response to testimony from Robert J. Beall, Ph.D., president and CEO of the Foundation, the legislation includes a provision requiring that special attention be given to research for rare diseases, such as [...]

Filed under: Congress, SBIR, patient groups | Tagged: Congress, cystic fibrosis, SBIR | No Comments »

Yesterday, the House voted overwhelmingly (368-43), to reauthorize the Small Business Innovation Research (SBIR) program.  This bill will allow more biotechnology companies to compete for research funding.
This act will increase access to early-stage funding for treatments and cures for debilitating diseases.  Congress has recognized the capital-intensive needs of emerging biotechnology companies, whose development of a [...]

Filed under: BIO, Congress, SBIR, patient groups, venture capital | Tagged: Committee, House, SBIR, Science, treatments | No Comments »

We chatted with Virginia Ladd, President and Executive Director of the American Autoimmune Related Disease Association.
What is the scope of your work?
There are over 100 types of autoimmune related diseases, including lupus, type I diabetes, scleroderma, celiac, multiple sclerosis, Crohn’s disease, autoimmune hepatitis, rheumatoid arthritis, Graves’ disease, and Sjogren’s syndrome. The NIH estimates that 23.5 [...]

Filed under: Finding Cures, Non Profit, SBIR, patient groups | Tagged: Autoimmune Related Disease, celiac, crohn's disease, multiple sclerosis, Virginia Ladd | No Comments »

It’s been a busy and productive week for SBIR reform advocates. The House Science Subcommittee on Technology and Innovation and the House Small Business Committee both marked up SBIR reauthorization legislation this week and expect to take a bill to the floor mid to late next week (week of 4/21). This is very positive news [...]

Filed under: Congress, SBIR | Tagged: biotech firms, House Science subcommittee, HR 5819, Phase I grants, pipeline, SBIR | No Comments »